Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease

Blood

Volumn 102, Issue 3, 2003, Pages 1114-1120

  Lion, Thomas ^a   Baumgartinger, Rosi ^b   Watzinger, Franz ^b   Matthes Martin, Susanne ^b   Suda, Magdalena ^b   Preuner, Sandra ^b   Futterknecht, Barbara ^b   Lawitschka, Anita ^b   Peters, Christina ^b   Pötschger, Ulrike ^b   Gadner, Helmut ^b  

^a CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ADENOVIRUS; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLOOD; CHILD; DISEASE ASSOCIATION; EARLY DIAGNOSIS; ENTERITIS; FECES; HEMATOLOGIC MALIGNANCY; HIGH RISK POPULATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING TEST; SYMPTOM; THROAT; URINE; VIRUS DIAGNOSIS; VIRUS IDENTIFICATION; VIRUS INFECTION;

EID: 0043245804     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-07-2152     Document Type: Article

References (46)

1. Flomenberg P, Piaskowski V, Harb J, Segura A, Casper JT. Spontaneous, persistent infection of a B-cell lymphoma with adenovirus. J Med Virol. 1996;48:267-272.
2. Shields AF, Hackman RC, Fife KH, Corey L, Meyers JD. Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med. 1985;312:529-533.
3. Blanke C, Clark C, Broun ER, et al. Evolving pathogens in allogeneic bone marrow transplanlatlon: increased fatal adenoviral infeclions. Am J Med. 1995;99:326-328.
4. Xu W, McDonough MC, Erdman DD. Species-specific identification of human adenoviruses by a multiplex PCR assay. J Clin Microbiol. 2000;38:4114-4120.
5. De Jong JC, Wermenbol AG, Verweij-Uijterwaal MW, et al. Adenoviruses from human immunodeficlency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively. J Clin Microbiol. 1999;37:3940-3945.
6. Kidd AH, Jonsson M, Garwicz D, et al. Rapid subgenus identification of human adenovirus isolates by a general PCR. J Clin Microbiol. 1996;34:622-627.
7. Benkö M, Harrach B, Russell WC. Family adeno-viridae. In: Van Regenmortel MHV, Fauquet CM, Bishop DKL, et al, eds. Virus Taxonomy: Seventh Report of the International Committee on Taxonomy of Viruses. New York: Academic Press; 1999:227-238.
8. Hierholzer JC. Adenoviruses in the immunocompromised host. Clin Microbiol Rev. 1992;5:262-274.
9. Morris DJ, Corbitt G, Bailey AS, et al. Fatal disseminated adenovirus type 2 infection following bone marrow transplantation for Hurler's syndrome: a primary infection. J Infect. 1993;26:181-184.
10. Chakrabarti S, Collingham KE, Fegan CD, Pillay D, Milligan DW. Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy? Bone Marrow Transplant. 2000;26:305-307.
11. Flomenberg P, Babbitt J, Drobyski WR, et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis. 1994;169:775-781.
12. La Rosa AM, Champlin RE, Mirza N, et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis. 2001;32:871-876.
13. Echavarria M, Forman M, van Tol MJ, Vossen JM, Charache P, Kroes AC. Prediction of severe disseminated adenovirus infection by serum PCR. Lancet. 2001;358:384-385.
14. Lankester AC, van Tol MJ, Claas EC, Vossen JM, Kroes AC. Quantification of adenovirus DNA in plasma for management of infection in stem cell graft recipients. Clin Infect Dis. 2002;34:864-867.
15. Legrand F, Berrebi D, Houhou N, et al. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant. 2001;27:621-626.
16. Ljungman P. Respiratory virus infections in bone marrow transplant recipients: the European perspective. Am J Med. 1997;102:44-47.
17. Runde V, Ross S, Trenschel R, et al. Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant. 2001;28:51-57.
18. Akalu A, Seidel W, Liebermann H, Bauer U, Dohner L. Rapid identification of subgenera of human adenovirus by serological and PCR assays. J Virol Methods. 1998;71:187-196.
19. Adam E, Nasz I, Lengyel A. Characterization of adenovirus hexons by their epitope composition. Arch Virol. 1996;141:1891-1907.
20. Baldwin A, Kingman H, Darville M, et al. Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplant. 2000;26:1333-1338.
21. Carrigan DR. Adenovirus infections in immunocompromised patients. Am J Med. 1997;102:71-74.
22. Hoffman JA, Shah AJ, Ross LA, Kapoor N. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2001;7:388-394.
23. Howard DS, Phillips GL 2d, Reece DE, et al. Adenovirus infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 1999;29:1494-1501.
24. Hale GA, Heslop HE, Krance RA, et al. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant. 1999;23:277-282.
25. Pring-Akerblom P, Trijssenaar FE, Adrian T, Hoyer H. Multiplex polymerase chain reaction for subgenus-specific detection of human adenoviruses in clinical samples. J Med Virol. 1999;58:87-92.
26. Lion T, Gaiger A, Henn T, et al. Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon. Leukemia. 1995;9:1353-1360.
27. Watzinger F, Lion T. Multiplex PCR for quality control of template RNA/cDNA in RT-PCR assays. Leukemia. 1998;12:1984-1986.
28. Munoz FM, Piedra PA, Demmler GJ. Disseminated adenovirus disease in immunocompromised and immunocompetent children. Clin Infect Dis. 1998;27:1194-1200.
29. Chroboczek J, Bieber F, Jacrot B. The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2. Virology. 1992;186:280-285.
30. Kinloch R, MacKay N, Mautner V. Adenovirus hexon: sequence comparison of subgroup C serotypes 2 and 5. J Biol Chem. 1984;259:6431-6436.
31. Scott-Taylor TH, Hammond GW. Conserved sequences of the adenovirus genome for detection of all human adenovirus types by hybridization. J Clin Microbiol. 1992;30:1703-1710.
32. Toogood CI, Murali R, Burnett RM, Hay RT. The adenovirus type 40 hexon: sequence, predicted structure and relationship to other adenovirus hexons. J Gen Virol. 1989;70:3203-3214.
33. Toogood CI, Hay RT. DNA sequence of the adenovirus type 41 hexon gene and predicted structure of the protein. J Gen Virol. 1988;69:2291-2301.
34. Flomenberg P, Gutierrez E, Piaskowski V, Casper JT. Detection of adenovirus DNA in peripheral blood mononuclear cells by polymerase chain reaction assay. J Med Virol. 1997;51:182-188.
35. Elnifro EM, Cooper RJ, Klapper PE, Bailey AS. PCR and restriction endonuclease analysis for rapid identification of human adenovirus subgenera. J Clin Microbiol. 2000;38:2055-2061.
36. Echavarria MS, Ray SC, Ambinder R, Dumler JS, Charache P. PCR detection of adenovirus in a bone marrow transplant recipient: hemorrhagic cystitis as a presenting manifestation of disseminated disease. J Clin Microbiol. 1999;37:686-689.
37. Echavarria M, Forman M, Ticehurst J, Dumler JS, Charache P. PCR method for detection of adenovirus in urine of healthy and human immunodeficiency virus-infected individuals. J Clin Microbiol. 1998;36:3323-3326.
38. Mentel R, Dopping G, Wegner U, Seidel W, Liebermann H, Dohner L. Adenovirus-receptor interaction with human lymphocytes. J Med Virol. 1997;51:252-257.
39. Hierholzer JC, Halonen PE, Dahlen PO, Bingham PG, McDonough MM. Detection of adenovirus in clinical specimens by polymerase chain reaction and liquid-phase hybridization quantitated by time-resolved fluorometry. J Clin Microbiol. 1993;31:1886-1891.
40. Venard V, Carret A, Corsaro D, Bordigoni P, Le Faou A. Genotyping of adenoviruses isolated in an outbreak in a bone marrow transplant unit shows that diverse strains are involved. J Hosp Infect. 2000;44:71-74.
41. Lion T, Henn T, Gaiger A, Kalhs P, Gadner H. Early detection of relapse after bone marrow transplantation in patients with chronic myelogenous leukaemia. Lancet. 1993;341:275-276.
42. Miyamura K, Hamaguchi M, Taji H, et al. Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors. Bone Marrow Transplant. 2000;25: 545-548.
43. Jurado CM, Hernandez MF, Navarro Mari JM, et al. Adenovirus pneumonitis successfully treated with intravenous ribavirin [letter]. Haematologica. 1998;83:1128-1129.
44. Hromas R, Cornetta K, Srour E, Blanke C, Broun ER. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation [letter]. Blood. 1994;84:1689-1690.
45. Bordigoni P, Carret AS, Venard V, Witz F, Le Faou A. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2001;32:1290-1297.
46. Regn S, Raffegerst S, Chen X, Schendel D, Kolb HJ, Roskrow M. Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant. Bone Marrow Transplant. 2001;27:53-64.